Tianjin Chase Sun Pharmaceutical News

Tianjin Chase Sun Pharmaceutical: Tianjin Hongri Pharmaceutical Co., Ltd. 2024 Follow-up Rating Report

May 30 04:30 ET

Tianjin Chase Sun Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice

May 16 05:06 ET

Tianjin Chase Sun Pharmaceutical: 2024 First Quarter Report

Apr 25 12:00 ET

Tianjin Chase Sun Pharmaceutical: 2024 First Quarter Report Disclosure Prompt Announcement

Apr 25 12:00 ET

Hongri Pharmaceutical: Announcement on the Company's Obtaining a Drug Registration Certificate

Apr 24 04:31 ET

Hongri Pharmaceutical: Notice on the Company's Completion of the Registration of the Legal Representative's Change of Trade

Apr 23 03:53 ET

Hongri Pharmaceutical: Legal Opinion of the 2023 Annual General Meeting of Shareholders

Apr 22 06:45 ET

Hongri Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

Apr 22 06:44 ET

Hongri Pharmaceutical: 300026 Hongri Pharmaceutical Investor Relations Management Information 20240419

Apr 19 06:09 ET

Hongri Pharmaceutical: Legal Opinion of the Third Extraordinary General Meeting of Shareholders in 2024

Apr 18 04:40 ET

Hongri Pharmaceutical: Announcement of Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders

Apr 18 04:40 ET

Hongri Pharmaceutical: Announcement on holding the 2023 Online Results Briefing

Apr 11 04:34 ET

Hongri Pharmaceutical: Joint Credit Assessment Co., Ltd.'s concern announcement regarding changes in the chairman and general manager of Tianjin Hongri Pharmaceutical Co., Ltd.

Apr 8 05:15 ET

Hongri Pharmaceutical: Interim Report of Tianfeng Securities Co., Ltd. on the fiduciary management matters of the resignation of the chairman of Tianjin Hongri Pharmaceutical Co., Ltd. and the by-election of directors, chairman, vice chairman, adjustment o

Apr 3 03:59 ET

Hongri Pharmaceutical: Announcement of Resolutions of the 17th Meeting of the Eighth Board of Directors

Apr 1 12:00 ET

Hongri Pharmaceutical: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024

Apr 1 12:00 ET

Hongri Pharmaceutical: Announcement on the Resignation of the Chairman of the Company and the By-election of Directors, Chairman of the Board, Vice Chairman, Adjustment of Special Committee Members, Changes in Legal Representatives, and Appointment of Comp

Apr 1 12:00 ET

Hongri Pharmaceutical: Legal Opinion of the 2024 Second Extraordinary General Meeting of Shareholders

Mar 29 05:12 ET

Hongri Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders

Mar 29 05:12 ET

Hongri Pharmaceutical: 2023 Supervisory Committee Work Report

Mar 28 12:00 ET